Resources
Clinical Trials
Essential3 study is an at-home research study evaluating an investigational drug, to see if it may improve your ability to complete everyday tasks, such as eating, drinking and dressing. The Essential3 study has been designed so that you may participate from the comfort of your own home. For more information, visit www.essential3study.com
To learn more about the EMBOLD study for children diagnosed with SCN2A and SCN8A DEEs, please visit www.emboldstudy.org
To learn more about the EMBRAVE study for children diagnosed with early-onset SCN2A DEEs, please visit www.embravestudy.org
Our Expanded Access Policy
Scientific Publications
Ulixacaltamide |
---|
2024 AAN Annual Meeting
|
2023 IAPRD Meeting |
2023 MDS Congress |
2022 AAN Annual Meeting
|
2022 MDS Congress
|
Ulixacaltamide Translational Findings in Movement Disorders
|
ET Claims Analysis in Advances in Therapy |
TTCC Mechanistic Review in Annals of Clinical and Translational Neurology |
Relutrigine (PRAX-562) |
---|
2024 EEC Meeting
|
2023 AES Behind the Seizure Scientific Exhibit; Partners Against Mortality in Epilepsy Conference
|
2023 IEC Meeting
|
2022 Epilepsy Foundation Pipeline Conference
|
2022 Familes of SCN2A and SCN8A Advocacy Talk |
2022 AES Annual Meeting and Behind the Seizure Scientific Exhibit |
2021 AES Annual Meeting
|
PRAX-562 Pharmacology in Epilepsia
|
Elsunersen (PRAX-222) |
---|
2024 EEC Meeting
|
2023 AES Annual Meeting and Behind the Seizure Scientific Exhibit; Partners Against Mortality in Epilepsy Conference |
2023 Oligonucleotides for CNS Meeting |
2022 AES Annual Meeting and Behind the Seizure Scientific Exhibit |
2022 Drug Discovery for Ion Channels XXII Meeting |
PRAX-628 |
---|
2024 EEC Meeting
|
2023 AES Annual Meeting and Behind the Seizure Scientific Exhibit
|
2023 AAN Annual Meeting
|
2023 IEC Meeting
|
Other |
---|
2024 EEC Meeting
|
2023 SYNGAP1 Conference
|
2021 AES Annual Meeting
|
PRX-2904 Chemistry in ACS Medicinal Chemistry Letters
|